Foreword; Preface; Acknowledgements; Part I. Cognitive Function, Neuropsychological Evaluation and Syndromes of Cognitive Impairment: 1.1. Attention; 1.2. General Intelligence, IQ; 1.3. Memory; 1.4. Language; 1.5. Perception; 1.6. Praxis; 1.7. Executive function - 'frontal function'; 1.8. 'Bedside' neuropsychological test instruments; 1.9. Normal aging; 1.10. Dementia, delirium, depression; 1.11. Cortical vs. subcortical dementia, thalamic dementia; 1.12. Disconnection syndromes; Part II. Neurodegenerative Disorders: 2.1. Alzheimer's disease (AD); 2.2. Frontotemporal lobar degenerations (FTLD); 2.3. Motor neurone disease (MND), amyotrophic lateral sclerosis (ALS); 2.4. Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD); 2.5. Prion diseases; 2.6. Mild cognitive impairment (MCI); Part III. Cerebrovascular Disease - Vascular Dementia and Vascular Cognitive Impairment: 3.1. Cortical vascular dementia, Multi-infarct dementia (MID), poststroke dementia; 3.2. Subcortical vascular dementia, Binswanger's disease, lacunar state, Subcortical ischaemic vascular disease (SIVD); 3.3. Strategic infarct dementia, strategic strokes; 3.4. Subarachnoid haemorrhage (SAH); 3.5. Intracranial vascular malformations; 3.6. Vasculopathies; 3.7. Other cerebrovascular disorders; Part IV. The Epilepsies: 4.1. Epilepsy and cognitive impairment; 4.2. Cognitive decline and epilepsy - shared aetiology; 4.3. Seizures causing acquired cognitive impairment; 4.4. Anti-epileptic drug therapy causing cognitive impairment; 4.5. Treatment of cognitive problems in epilepsy; Part V. Neurogenetic Disorders: 5.1. Hereditary dementias; 5.2. Hereditary ataxias; 5.3. Hereditary spastic paraplegia; 5.4. Hereditary movement disorders; 5.5. Hereditary metabolic disorders; 5.6. Hereditary neurocutaneous syndromes (phakomatoses); Part VI. Inflammatory, Immune-mediated and Systemic Disorders: 6.1. Multiple sclerosis; 6.2. Acute disseminated encephalomyelitis (ADEM); 6.3. Sarcoidosis; 6.4. Systemic lupus erythematosus (SLE); 6.5. Sjoegren's syndrome; 6.6. Behcet's disease; 6.7. Rheumatoid arthritis (RhA); 6.8. Scleroderma, systemic sclerosis; 6.9. Relapsing polychondritis; 6.10. Cerebral vasculitis; 6.11. Sydenham's chorea, Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS); 6.12. Limbic encephalitis; 6.13. Hashimoto's encephalopathy; 6.14. Erdheim-Chester disease; 6.15. Bilateral vestibulopathy; Part VII. Structural Brain Lesions: 7.1. Brain tumours and their treatment; 7.2. Hydrocephalic dementias; 7.3. Other structural lesions; Part VIII. Endocrine, Metabolic, and Toxin-Related Disorders: 8.1. Endocrine disorders; 8.2. Metabolic disorders; 8.3. Toxin-related disorders; Part IX. Infective Disorders: 9.1. Encephalitides and meningoencephalitides; 9.2. Meningitides; 9.3. Human immunodeficiency virus (HIV) and related conditions; 9.4. Other disorders of infective aetiology; Part X. Neuromuscular Disorders: 10.1. Myotonic dystrophy (Steinert disease); 10.2. Myasthenia gravis; Index.
